Replies to post #823314 on NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Where does that 10.5 year survival data for NICE reimbursement fit into this that you were pumping since last year?

[flipper44]

Note: Still no public update on minutes from end of February UK CHM meeting?

[Doc logic]

flipper44,

Full approval puts lots of pressure on NICE and NWBO to come to terms quickly. That likely won’t happen without Flaskworks having been made ready to be placed into the immediate testing and GMP integration process. The timing for this and the regulatory runway regarding ECAs for MHRA cover seem to be the two most critical aspects regarding timing of approval along with the increased reimbursement rate making a shortened transition time with less dilution possible. Best wishes.

[skitahoe]

Flipper,  
It's very possible that the company is also involved with how conditional trials can be designed.  I would hate to see trials that didn't include the therapeutics that Dr. Liau has found so effective.  Why would anyone enter a trial that provides 13% survival at 5 years when a combination that includes the vaccine can get 50% survival. 
Gary